<DOC>
	<DOCNO>NCT01098019</DOCNO>
	<brief_summary>Patients randomize ( 1:1 ) receive either injection Xeomin 0.9 % NaCl NaCl alone . Xeomin reconstitute 2 mL NaCl 0.9 give final concentration 5 U botulinum toxin A per 0.1 mL . The area affect injected 0.1 mL 1-2 cm2 maximum total dose 200 unit . Patients evaluate Weeks 8 , 12 , 18 24 . An unblinded pharmacist designee prepare placebo Xeomin injection . Patients unblinded end week 12 visit . After unblinding ( week 12 ) patient randomize placebo receive Xeomin patient initially randomize Xeomin inject . All patient see follow-up visit Weeks 18 24 . Efficacy reduce pruritus measure 10 cm visual analogue score . This perform Day 0 , Week 8 , Week 12 , Week 18 Week 24 . Efficacy also measure measure area hyperpigmented zone back . Safety evaluate adverse event .</brief_summary>
	<brief_title>Treatment Notalgia Paresthetica With Xeomin</brief_title>
	<detailed_description>Notalgia paresthetica common sensory neuropathy , affect mainly interscapular area especially T2-T6 dermatome . The characteristic symptom pruritus upper back . It occasionally accompany pain , paresthesia , hyperesthesia well circumscribed hyperpigmentation affect area . The correlation notalgia paresthetica localization correspond degenerative change spine suggest spinal nerve impingement may contribute cause . Topical treatment corticosteroid , menthol , capsaicine pramoxine usually effective . Patients affect daily activity chronic condition usually disappointed current available treatment . A recent publication report success treat 2 patient notalgia paresthetica botulinum toxin A . In case complete response pruritus note . The major limitation publication small number case ( two ) fact control . The mechanism action botulinum toxin A nostalgia paresthetica investigate . However beneficial effect botulinum toxin A diseases cause pruritus pain previously report . Botulinum toxin A show prevent release substance P , well know mediator involve pain itch , may explain efficacy pruritic disease . This proposal plan study efficacy safety botulinum toxin A ( Xeomin ) treatment notalgia paresthetica randomize placebo control trial . Botulinum toxin A prevents release neuromediators acetylcholine . Botulinum toxin A use many year treat various disorder include blepharospasm , spasmodic torticollis , post stroke spasticity upper limb , strabismus , palmar axillary hyperhidrosis wrinkle . This study use Xeomin , purify botulinum clostridium neurotoxin A recently approve Health Canada . Xeomin currently approve treatment blepharospasm , spasmodic torticollis post stroke spasticity upper limb . A recent publication report success treat two patient notalgia paresthetica botulinum toxin A . In case complete response pruritus note . One patient still symptom free 18 month patient mild resurgence pruritus 18 month . The major limitation publication small number case ( two ) fact control . The current proposal plan study efficacy safety botulinum toxin A treatment notalgia paresthetica randomize placebo control trial . In study Xeomin reconstitute used accord approved Canadian Product Monograph .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men woman 18 75 year age time consent Presence notalgia paresthetica , resistant topical therapy , least one year stable past 3 month prior Day 0 . Unless surgically sterile ( least 1 year postmenopausal woman ) , abstinent , patient ( male female ) willing use effective method contraception least 30 day Day 0 least 12 month last drug administration . Effective method contraception include : 1 . Condom spermicidal foam jelly , sponge spermicidal foam jelly , diaphragm spermicidal foam jelly 2 . Intra uterine device ( IUD ) 3 . Contraceptives ( oral parenteral ) 4 . Nuvaring 5 . Vasectomy vasectomise partner 6 . Surgically sterile postmenopausal partner 7 . Samesex partner Capable give informed consent ; consent must obtain prior study related procedure . Negative urine pregnancy test ( female childbearing potential ) Current Pregnancy lactation Very mild notalgia paresthetica define absence clear zone hyperpigmentation affect area back Severe notalgia paresthetica define presence excoriation , erosion significant scar affected area back Use topical treatment affect area within 14 day Day 0 Use botulinum toxin A within past 12 week Day 0 Previous use botulinum toxin A affect area back Use systemic medication influence pruritus antihistamine within 14 day Day 0 Use systemic corticosteroid within 28 day Day 0 Hypersensitivity Xeomin Generalized disorder muscle activity ( e.g . myasthenia gravis , Lambert Eaton syndrome ) Presence infection affect area back</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Notalgia paresthetica</keyword>
	<keyword>Xeomin</keyword>
	<keyword>Botulinum Toxin A</keyword>
	<keyword>Pruritus</keyword>
	<keyword>Upper Back</keyword>
	<keyword>Hyperpigmentation</keyword>
</DOC>